These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14986591)

  • 1. High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
    Yeh KH; Lu YS; Hsiao CH; Cheng AL
    Anticancer Res; 2003; 23(6D):5133-7. PubMed ID: 14986591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
    Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
    J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
    Long HJ; Blessing JA; Sorosky J
    Gynecol Oncol; 2005 Nov; 99(2):339-42. PubMed ID: 16051328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Blessing JA; Malfetano JH
    Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic lung tumor from uterine leiomyosarcoma].
    Nishida T; Shoji S; Itoh T; Minami H; Akizuki K; Ozuno I; Kageyama H; Ozaki I; Yamamoto K; Yamamoto A; Nishiyama N
    Kyobu Geka; 2006 Dec; 59(13):1191-6. PubMed ID: 17163213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung.
    Yeh KH; Cheng AL
    Anticancer Res; 1997; 17(2B):1341-3. PubMed ID: 9137495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
    Hadoux J; Rey A; Duvillard P; Lhommé C; Balleyguier C; Haie-Meder C; Morice P; Tazi Y; Leary A; Larue C; Pautier P
    Int J Gynecol Cancer; 2015 Feb; 25(2):296-302. PubMed ID: 25581897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy CYVADIC and adriamycin (injected intratumorally) result in a partial response for six months in uterine sarcoma recurrence].
    Higashijima H; Yoh S; Kataoka A; Arimatsu T; Tanaka H; Araki T; Nishida K; Umezu J
    Igaku Kenkyu; 1986 Jun; 56(2):77-84. PubMed ID: 3564864
    [No Abstract]   [Full Text] [Related]  

  • 9. Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.
    Nappi L; Di Spiezio Sardo A; Indraccolo U; Bettocchi S
    J Minim Invasive Gynecol; 2008; 15(3):380-3. PubMed ID: 18439518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide with and without adriamycin in advanced uterine leiomyosarcoma.
    Hawkins RE; Wiltshaw E; Mansi JL
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S26-9. PubMed ID: 2347045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas.
    Pearl ML; Inagami M; McCauley DL; Valea FA; Chalas E; Fischer M
    Int J Gynecol Cancer; 2002; 12(6):745-8. PubMed ID: 12445253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic uterine leiomyosarcoma with cisplatin, pirarubicin, and ifosfamide.
    Hirota Y; Miyamura K; Hayata T; Miyakawa I
    Gynecol Obstet Invest; 1997; 44(1):70-2. PubMed ID: 9251960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
    Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
    Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoid leiomyosarcoma of the uterus.
    Kunzel KE; Mills NZ; Muderspach LI; d'Ablaing G
    Gynecol Oncol; 1993 Feb; 48(2):277-80. PubMed ID: 8428703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
    Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.
    Edmonson JH; Marks RS; Buckner JC; Mahoney MR
    Cancer Invest; 2002; 20(5-6):605-12. PubMed ID: 12197215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant CYVADIC (cyclophosphamide, vincristine, adriamycin and dacarbazine) therapy for retroperitoneal leiomyosarcoma: a case report].
    Kamba T; Kawakita M; Noguchi T; Kamoto T; Okabe T; Takeuchi E; Matsumoto M
    Hinyokika Kiyo; 1997 Aug; 43(8):577-80. PubMed ID: 9310781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
    Hardman MP; Roman JJ; Burnett AF; Santin AD
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):518-20. PubMed ID: 17666649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remission due to CYVADIC chemotherapy of primary leiomyosarcoma derived from mesentelium of the sigmoid colon: a case report].
    Takano M; Kita T; Kikuchi Y; Nagata I
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1487-90. PubMed ID: 10500540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
    Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
    Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.